The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Cognitive decline in Parkinson disease
Open accessAbstract
Dementia is a frequent problem encountered in advanced stages of Parkinson disease (PD). In recent years, research has focused on the pre-dementia stages of cognitive impairment in PD, including mild cognitive impairment (MCI). Several longitudinal studies have shown that MCI is a harbinger of dementia in PD, although the course is variable, and stabilization of cognition - or even reversal to normal cognition - is not uncommon. In addition to limbic and cortical spread of Lewy pathology, several other mechanisms are likely to contribute to cognitive decline in PD, and a variety of biomarker studies, some using novel structural and functional imaging techniques, have documented in vivo brain changes associated with cognitive impairment. The evidence consistently suggests that low cerebrospinal fluid levels of amyloid-β 42, a marker of comorbid Alzheimer disease (AD), predict future cognitive decline and dementia in PD. Emerging genetic evidence indicates that in addition to the APOE*ε4 allele (an established risk factor for AD), GBA mutations and SCNA mutations and triplications are associated with cognitive decline in PD, whereas the findings are mixed for MAPT polymorphisms. Cognitive enhancing medications have some effect in PD dementia, but no convincing evidence that progression from MCI to dementia can be delayed or prevented is available, although cognitive training has shown promising results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover there are several candidate genetic risk factors that overlap for AD and PD, most notably APOE and MAPT [127].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationLitvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,346
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationMultimodal classification of Alzheimer's disease and mild cognitive impairment
Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.008 · Cited by 1,340
Cited by
Sorted by citations
Items 601–700 of 1,000
Liu, Y., Ding, L., Xianyu, Y., Nie, S., & Yang, J. (2022) · Medicine · doi:10.1097/md.0000000000029931 · Cited by 7
Pinizzotto, C. C., Dreyer, K. M., Oluwagbohunmi, A., Caffrey, R. M., Madhira, K., & Kritzer, M. F. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.951268 · Cited by 7
Ohno, Y., Okita, E., Kawai-Uchida, M., Fukuda, N., Shoukei, Y., Soshiroda, K., Yamada, K., Kanda, T., & Uchida, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175773 · Cited by 7
Gao, H., Qu, Y., Chen, S., Yang, Q., Jing-Yi, L., Tao, A., Mao, Z., & Xue, Z. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14360 · Cited by 7
Prete, M., Cellini, N., Ronconi, L., & Rosa, E. D. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.09.009 · Cited by 7
Impaired Cognition and the Risk of Parkinson Disease
Brown, E. G., & Tanner, C. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1474 · Cited by 7
Temperament traits and executive functions in Parkinson’s disease
Luca, A., Nicoletti, A. S. Q., Mostile, G., Sciacca, G., Dibilio, V., Cicero, C. E., Raciti, L., Donzuso, G., & Zappia, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.040 · Cited by 7
Niethammer, M., & Eidelberg, D. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.10.004 · Cited by 7
Broche‐Pérez, Y., Bartuste-Marrer, D., Batule-Domínguez, M., & Toledano‐Toledano, F. (2019) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn13-040005 · Cited by 8
Striatal dopamine transporters and cognitive function in Parkinson’s disease
Stögbauer, J., Rosar, F., Dillmann, U., Fassbender, K. C., Ezziddin, S., & Spiegel, J. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13320 · Cited by 7
Masih, A., Agnihotri, A. K., Srivastava, J. K., Pandey, N., Bhat, H. R., & Singh, U. P. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22659 · Cited by 7
Arithmetic Errors in Financial Contexts in Parkinson’s Disease
Loenneker, H. D., Becker, S., Nussbaum, S., Nuerk, H., & Liepelt‐Scarfone, I. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.629984 · Cited by 7
Managing Advanced Parkinson Disease
Hwang, H., & Norris, S. A. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211018277 · Cited by 7
A new tool to identify patients with Parkinson's disease at increased risk of dementia
Aarsland, D., Creese, B., & Chaudhuri, К. R. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30170-9 · Cited by 7
Self-citationZhong, Y., Huang, S., Zou, M., Chen, Y., Shen, P., He, Y., Li, Y., Liu, C., & Chen, Z. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1592464 · Cited by 6
Colautti, L., Casella, M., Robba, M., Marocco, ., Ponticorvo, M., Iannello, P., Antonietti, A., Marra, C., & Database, F. T. C. I. P. (2025) · Brain Sciences · doi:10.3390/brainsci15080782 · Cited by 6
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes
Hey, G. E., Eisinger, R. S., Guarín, D. L., Safarpour, D., Rodríguez‐Violante, M., & Ramirez‐Zamora, A. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2552784 · Cited by 7
Maggio, M. G., Rizzo, A., Benenati, A., Giambò, F. M., Cannavò, A., Pasquale, P. D., Luca, R. D., Quartarone, A., & Calabrò, R. S. (2025) · Digital Health · doi:10.1177/20552076251376534 · Cited by 6
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Zhang, L., Gu, L., Dai, S., Zheng, R., Jin, C., Fang, Y., Yang, W., Tian, J., Yin, X., Zhao, G., et al. (2021) · European Neurology · doi:10.1159/000517538 · Cited by 6
Cheng, W., Fang, K., Ouyang, X., Jin, L., Song, Y., & Yu, B. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105871 · Cited by 6
Tsai, S.-T., Wei, T.-H., Yang, Y., Lu, M., San, S., Tsai, C., & Lin, Y. (2021) · PubMed Central · doi:10.22038/ijbms.2021.56156.12531 · Cited by 6
Cerebral microbleeds is associated with dementia in Parkinson’s disease
Wan, H., Chen, H., Zhang, M., Feng, T., & Wang, Y. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01918-z · Cited by 6
Association of Plasma and Electroencephalography Markers With Motor Subtypes of Parkinson’s Disease
Yang, X., Li, Z., Bai, L., Shen, X. Y., Wang, F., Han, X., Zhang, R., Li, Z., Zhang, J., Dong, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.911221 · Cited by 6
Risk factors for dementia in Parkinson’s Disease — the overuse of anticholinergic drugs
Malkiewicz, J. J., Kasprzyk, A., Waksmundzki, D., Węgrzynek‐Gallina, J., Chmiela, T., & Siuda, J. S. (2023) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2023.0041 · Cited by 6
Attanayake, A. P., & Jayatilaka, K. A. P. W. (2018) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v6i5.437 · Cited by 6
Park, C. H., Yang, P.-S., Yoon, Y. S., & Ra, J.-C. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.12.031 · Cited by 6
Tajiri, Y., Wada‐Isoe, K., Tanaka, K., Adachi, T., Hanajima, R., & Nakashima, K. (2020) · Yonago acta medica · doi:10.33160/yam.2020.02.004 · Cited by 6
Non-motor Symptoms in Parkinson’s Disease
Vuletić, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-38606-1_9 · Cited by 6
Huang, Y., Wang, Y., Gao, Y., Liu, Q., Ye, F.-F., Guo, B., Wu, Y.-C., & Xue, L. (2020) · Nano LIFE · doi:10.1142/s1793984420400073 · Cited by 6
Executive function network’s white matter alterations relate to Parkinson’s disease motor phenotype
Yang, Q., Nanivadekar, S., Taylor, P. A., Dou, Z., Lungu, C., & Horovitz, S. G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135486 · Cited by 6
Animal models of action control and cognitive dysfunction in Parkinson's disease
Balleine, B. W. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.006 · Cited by 5
Filgrastim (G-CSF) ameliorates Parkinsonism l -dopa therapy’s drawbacks in mice
El‐Esawy, R. O., Balaha, M. F. H., Kandeel, S., Hadya, S., & Rahman, M.-N. A.-E. (2018) · Basal Ganglia · doi:10.1016/j.baga.2018.06.001 · Cited by 6
Jenny, A. L., Meyer, A., Handabaka, I., Calabrese, P., Fuhr, P., & Gschwandtner, U. (2020) · Parkinson s Disease · doi:10.1155/2020/7953032 · Cited by 6
Patai, E. Z., Foltynie, T., Limousin, P. D., Akram, H., Zrinzo, L. U., Bogacz, R., & Vladimir Litvak, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.09.141713 · Cited by 6
Cheng, Y., You, S., Wang, X., Ge, Y., Li, L., Ren, T., Chen, S., He, G., & Xue, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1620118 · Cited by 5
Lee, J. H., Park, M., Ahn, S. J., Lee, J., Ryu, Y. H., Yoo, H. S., & Lyoo, C. H. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251396322 · Cited by 5
Child, B., Beu, N., Saywell, I., da Silva, R., Collins‐Praino, L. E., & Baetu, I. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-025-01343-8 · Cited by 5
Hoffman, L., Burt, N. D., Piniella, N. R., Baker, M., Volino, N., Yasin, S., Jung, M., Leder, A. N., & Sousa, A. (2023) · Parkinson s Disease · doi:10.1155/2023/6645554 · Cited by 5
Erol, A. Y. G., Koçancı, F. G., Akıncı, E., Dora, D. D., Erendor, F., Şanlıoğlu, S., & Uysal, H. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16273 · Cited by 5
Cognitive function in different motor subtypes of Parkinson's disease: A systematic review protocol
Child, B., Saywell, I., da Silva, R., Collins‐Praino, L. E., & Baetu, I. (2024) · Health Science Reports · doi:10.1002/hsr2.2092 · Cited by 5
Clinical characteristics and treatment of psychosis in Parkinson’s disease: A narrative review
Stamenović, J., Živadinović, B., & Đurić, V. (2024) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001146 · Cited by 5
Florijn, B. W., van Zwet, E. W., Kaptein, A. A., & van der Plas, A. A. (2024) · Neurological Research and Practice · doi:10.1186/s42466-024-00340-5 · Cited by 5
Early BMI Change, Cognitive Decline, and CSF AD Biomarkers Alterations in Parkinson's Disease
Zhong, R., & Zhang, K. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70018 · Cited by 5
Brown, G. L., Du, G., Farace, E., Lewis, M. M., Eslinger, P. J., McInerney, J., Kong, L., Li, R., Huang, X., & Jesus, S. D. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212833 · Cited by 5
Face name matching and memory complaints in Parkinson’s disease
Siquier, A., & Andrés, P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1051488 · Cited by 5
Schümann, F., Schmitt, O., Wree, A., & Hawlitschka, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021685 · Cited by 5
Visuospatial memory profile of patients with Parkinson’s disease
França, M., Lima, J. P., Oliveira, A. B. F. D., Rosas, M. J., Vicente, S., & Sousa, C. (2023) · Applied Neuropsychology Adult · doi:10.1080/23279095.2023.2256918 · Cited by 5
Transcranial Ultrasound Stimulation Improves Memory Performance of Parkinsonian Mice
Zhao, Z., Ji, H., Pei, J., Yan, J., Zhang, X., Yuan, Y., & Liu, M. (2024) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2024.3378109 · Cited by 5
Kozak, V. V., Chaturvedi, M., Gschwandtner, U., Hatz, F., Meyer, A., Röth, V., & Fuhr, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00171 · Cited by 5
Marino, B. L. B., Sousa, K. P. A., Santos, C. B. R., Taft, C. A., da Silva, C. H. T. D. P., & Hage-Melim, L. I. D. S. (2021) · Engineering materials · doi:10.1007/978-3-030-62226-8_20 · Cited by 5
Schroeders, U., Zimmermann, J., Wicke, T., Schaumburg, M., Lang, E., Trenkwalder, C., & Mollenhauer, B. (2022) · Neuropsychology · doi:10.1037/neu0000795 · Cited by 5
Synchronization to auditory and visual beats in Parkinson's disease
Wu, Q., Zhou, Y., Li, M., Mei, X., Wu, Y., Fu, W., & Wu, X. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.08.029 · Cited by 5
Borgnis, F., Baglio, F., Pedroli, E., Rossetto, F., Meloni, M., Riva, G., & Cipresso, P. (2021) · Applied Sciences · doi:10.3390/app11156791 · Cited by 5
Machine learning-based prediction of cognitive outcomes in de novo Parkinson's diseasePreprint
Harvey, J., Reijnders, R. A., Cavill, R., Duits, A., Köhler, S., Eijssen, L., Rutten, B. P. F., Shireby, G. L., Torkamani, A., Creese, B., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1321402/v1 · Cited by 5
Self-citationHigginbotham, L. A., Rathore, S., Shantaraman, A., Guo, Q., Fox, E. J., Bagchi, P., Wu, F., Denkinger, M. N., Hanley, D., Ashton, N. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658994 · Cited by 7
Lee, D., Kim, H.-R., Park, Y. J., Ahn, Y., Lee, D., Lee, J., Chung, S. J., Kim, S. Y., Hwang, Y., Yun, J. Y., et al. (2025) · Journal of Movement Disorders · doi:10.14802/jmd.25135 · Cited by 4
Hajebrahimi, F., Budak, M., Sarıcaoğlu, M., Temel, Z., Demir, T. K., Hanoğlu, L., Yıldırım, S., & Bayraktaroğlu, Z. (2024) · Brain and Behavior · doi:10.1002/brb3.3395 · Cited by 4
Converse, A. K., Krasko, M. N., Rudisch, D. M., Lenell, C., Nisbet, A. F., Slesarev, M. S., Szot, J. C., Hoerst, A. G., LEVERSON, G. E., Gallagher, C. L., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1451118 · Cited by 3
Nguyen, T. P. P., Thibault, D. P., Gray, S. L., Weintraub, D. A., & Willis, A. W. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887241313376 · Cited by 5
Self-citationHemispheric asymmetry in neurodegenerative diseases
Cappa, S. F. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-15646-5.00009-9 · Cited by 4
Investigation of symptom-specific functional connectivity patterns in Parkinson’s disease
Kıçık, A., Bayram, A., Erdoğdu, E., Kurt, E., Arslan, D. B., Cengiz, S. D., Bılgıç, B., HANAĞASI, H. A., Öztürk-Işık, E., Gurvit, H. I., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08287-4 · Cited by 4
Visuospatial impairment in Parkinson's Disease: why we should keep an eye on it
Oliveira, H. S. D., Camargos, S., Cardoso, F., & Caramelli, P. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.108064 · Cited by 4
Association between frailty and cognitive function: a pooled analysis of three ageing cohorts
Zhang, X., Bo, Y., Li, Z., Xu, Y., Wang, J., Wang, X., Zhang, H., Zhang, J. J., Huang, J., Tao, Y., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03674-z · Cited by 4
Paroxysmal Slow-Wave Events Are Uncommon in Parkinson’s Disease
Milikovsky, D. Z., Sharabi, Y., Giladi, N., Mirelman, A., Sosnik, R., Fahoum, F., & Maidan, I. (2023) · Sensors · doi:10.3390/s23020918 · Cited by 4
Peng, Y., He, J., Xiang, H., Xie, L., She, J., Cheng, D., Liu, B., Hu, J. R., & Qian, H. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02204-8 · Cited by 4
Li, C., Li, M., Jin, Y., An, Q., Dang, H., & Gong, W. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112509 · Cited by 4
Gupta, V., & Prasad, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04392-1 · Cited by 4
Brandão, P. R. D. P., Pereira, D. A., Grippe, T. C., Bispo, D. D. D. C., Maluf, F. B., Titze‐de‐Almeida, R., Castro, B. M. D. A. E., Munhoz, R. P., Tavares, M. C. H., & Cardoso, F. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1362165 · Cited by 4
Shah, S., Tereda, A., & Mansour, H. M. (2024) · Current Genetic Medicine Reports · doi:10.1007/s40142-024-00210-1 · Cited by 6
Xiang, L., Xu, R., Zhou, X., Ren, X., Li, Z., & Wu, I. X. Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.065 · Cited by 4
Matias, K. V., Gonçalves, V., Scorza, F. A., Finsterer, J., Ciconelli, R. M., & Scorza, C. A. (2025) · Molecules · doi:10.3390/molecules30081672 · Cited by 6
Zhu, Z., Zhang, R., Chi, Y., Li, W., & Gong, W. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04484-x · Cited by 4
Role of food or food component in brain health
Ghosh, D. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00002-1 · Cited by 4
Behavioral Characterizing of CD24 Knockout Mouse—Cognitive and Emotional Alternations
Nitzan, K., Toledano, R., Shapira, S., Arber, N., & Doron, R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020105 · Cited by 4
Carlesimo, G. A., Taglieri, S., Zabberoni, S., Scalici, F., Peppe, A., Caltagirone, C., & da Costa, A. L. C. (2021) · Journal of Neuropsychology · doi:10.1111/jnp.12256 · Cited by 4
Tzeng, I. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24274 · Cited by 4
Sánchez-Rodríguez, J. L., Juárez‐Vela, R., Santolalla‐Arnedo, I., de Viñaspre‐Hernández, R. R., & González, J. L. S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040539 · Cited by 4
Investigating key factors underlying neurodegeneration linked to alpha‐synuclein spread
Pang, C. C.-C., Sørensen, M. H., Lee, K., Luk, K. C., Trojanowski, J. Q., Lee, V. M. ‐., Noble, W. J., & Chang, R. C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12829 · Cited by 4
Tülay, E. E., Yıldırım, E., Aktürk, T., & Güntekin, B. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/acc612 · Cited by 4
Backman, E. A., Saari, L., Parkkola, R. K., Koikkalainen, J. R., Gardberg, M., & Kaasinen, V. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.122804 · Cited by 4
Gates, K., Knowles, T., Mach, H., & Higginbotham, D. J. (2024) · American Journal of Speech-Language Pathology · doi:10.1044/2024_ajslp-23-00396 · Cited by 5
Furlepa, M., Zhang, Y. P., Lobanova, E., Kahanawita, L., Vivacqua, G., Williams‐Gray, C. H., & Klenerman, D. (2024) · Brain Communications · doi:10.1093/braincomms/fcae178 · Cited by 4
Physical Activity May Reduce Apolipoprotein E4-Associated Cognitive Decline in Parkinson Disease
Raber, J., Darweesh, S. K. L., & Savica, R. (2021) · Neurology · doi:10.1212/wnl.0000000000011851 · Cited by 4
MARTA: a model for the automatic phonemic grouping of the parkinsonian speechPreprint
Guerrero-López, A., Arias-Londoño, J. D., Shattuck‐Hufnagel, S., & Godino-Llorente, J. I. (2024) · doi:10.36227/techrxiv.171084943.31044695/v1 · Cited by 4
Imaging of Disease-Related Networks in Parkinson's DiseasePreprint
Nakano, Y., Niethammer, M., & Eidelberg, D. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041841 · Cited by 4
Joint-tissue integrative analysis identifies high-risk genes for Parkinson’s disease
Wu, Y.-S., Zheng, W.-H., Liu, T., Sun, Y., Xu, Y., Shao, L., Cai, Q., & Tang, Y. Q. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1309684 · Cited by 3
Murueta‐Goyena, A., Pino, R. D., Carmona‐Abellán, M., Tijero, B., Ruíz-López, M., Acera, M., Morera‐Herreras, T., Miguélez, C., Sáez-Atxukarro, O., Fernández‐Valle, T., et al. (2025) · Neurología · doi:10.1016/j.nrl.2023.02.008 · Cited by 3
Lee, J. H., Kim, H., Ahn, S. J., Park, M., Yoo, H. S., & Lyoo, C. H. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00880-w · Cited by 3
Zhou, Y., Li, Y., He, Q., Kong, Z., Yu, R., Yu, X., & Xie, A. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70522 · Cited by 3
Ortiz-Pérez, D., Benavent-Lledó, M., Garcia-Rodriguez, J., Tomás, D., & Vizcaya-Moreno, M. F. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.113787 · Cited by 6
Xi, J., Tang, C., Xiao, X., Chen, M., Zou, Q., & Zhou, X. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03379-24 · Cited by 3
Pan, C., Zhao, E., Ren, J., Zhou, G., Wang, Y., Zhang, R., Shen, Y., Liu, W., & Chen, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1685244 · Cited by 3
Alam, T., Burney, W. A., Kamal, S., Kamal, A., Abufatima, I. O., Ali, U., Mukhlis, M., Khatri, A., Usman, N., Aqeel, N., et al. (2026) · Brain and Behavior · doi:10.1002/brb3.71190 · Cited by 3
Abid, H., Memon, S., Das, V., Fatima, K., Mukhlis, M., & Vazaym, M. (2026) · NeuroSci · doi:10.3390/neurosci7030066 · Cited by 3
Ma, R., Hou, Y., Zhang, Y., He, M., Gao, S., Kaudimba, K. K., Lin, K., Jin, L., Liu, T., & Wang, R. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.731606 · Cited by 3
Psychobiotics in Health, Longevity, and Neurological Disorders
Mohankumar, A., Kalaiselvi, D., Thiruppathi, G., Patteswari, D., Tawata, S., & Sundararaj, P. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-8158-5_2 · Cited by 3
Chen, Z., Zhang, W., He, W., Yang, G., Yu, T., Du, Y., & Li, R. (2023) · BMC Neurology · doi:10.1186/s12883-023-03057-1 · Cited by 3
The antisaccadic paradigm: A complementary neuropsychological tool in basal ganglia disorders
Hapáková, L., Necpál, J., & Košutzká, Z. (2024) · Cortex · doi:10.1016/j.cortex.2024.06.005 · Cited by 3
Souto, J. J. S., de Oliveira, M. E. C., Silva, G. M., de Sousa, J. M. N., Franco, C. I. F., & dos Santos, N. A. (2024) · Applied Neuropsychology Adult · doi:10.1080/23279095.2024.2367108 · Cited by 4
Wolters, A., Temel, Y., Clusmann, H., & Hescham, S. (2024) · Deep Brain Stimulation · doi:10.1016/j.jdbs.2024.07.003 · Cited by 4
Metadata
- Authors
- Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C.
- Affiliations
- King's College London (GB)
- Corresponding author
- Aarsland, Dag
- Venue
- Nature Reviews Neurology
- Published
- 2017-03-03
- Volume
- 13
- Issue
- 4
- Pages
- 217-231
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC5643027
- OpenAlex
- W2593272776
- Cited by
- 1,027
- References
- 216
- Citations by year
- 2026: 102 · 2025: 99 · 2024: 138 · 2023: 104 · 2022: 105 · 2021: 171 · 2020: 116 · 2019: 89 · 2018: 68 · 2017: 33
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- National Institute of Neurological Disorders and Stroke (P50NS053488)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Parkinson's disease, cognitive decline, Parkinson's disease dementia, mild cognitive impairment, cerebrospinal fluid biomarkers, amyloid-beta 42, Lewy body pathology, APOE ε4, GBA mutations, cognitive training, nootropic drugs
- MeSH terms
- Dementia, Humans, Parkinson Disease, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
